- Home
- BATL vs ADVB Comparison
BATL vs ADVB Comparison
Compare BATL & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- ADVB
- Stock Information
- Founded
- BATL 1987
- ADVB 2014
- Country
- BATL United States
- ADVB United States
- Employees
- BATL N/A
- ADVB N/A
- Industry
- BATL Oil & Gas Production
- ADVB Medical Specialities
- Sector
- BATL Energy
- ADVB Health Care
- Exchange
- BATL Nasdaq
- ADVB Nasdaq
- Market Cap
- BATL 21.7M
- ADVB 20.8M
- IPO Year
- BATL N/A
- ADVB 2025
- Fundamental
- Price
- BATL $1.13
- ADVB $0.44
- Analyst Decision
- BATL
- ADVB
- Analyst Count
- BATL 0
- ADVB 0
- Target Price
- BATL N/A
- ADVB N/A
- AVG Volume (30 Days)
- BATL 53.1K
- ADVB 2.3M
- Earning Date
- BATL 08-14-2025
- ADVB 08-26-2025
- Dividend Yield
- BATL N/A
- ADVB N/A
- EPS Growth
- BATL N/A
- ADVB N/A
- EPS
- BATL N/A
- ADVB N/A
- Revenue
- BATL $185,206,000.00
- ADVB N/A
- Revenue This Year
- BATL N/A
- ADVB N/A
- Revenue Next Year
- BATL N/A
- ADVB N/A
- P/E Ratio
- BATL N/A
- ADVB N/A
- Revenue Growth
- BATL N/A
- ADVB N/A
- 52 Week Low
- BATL $1.05
- ADVB $0.34
- 52 Week High
- BATL $6.89
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- BATL 35.05
- ADVB N/A
- Support Level
- BATL $1.25
- ADVB N/A
- Resistance Level
- BATL $1.31
- ADVB N/A
- Average True Range (ATR)
- BATL 0.07
- ADVB 0.00
- MACD
- BATL -0.01
- ADVB 0.00
- Stochastic Oscillator
- BATL 9.09
- ADVB 0.00
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.